Provided by Tiger Trade Technology Pte. Ltd.

Molecular Partners AG

4.40
+0.16994.02%
Post-market: 4.400.00000.00%17:18 EDT
Volume:504
Turnover:2.21K
Market Cap:164.55M
PE:-2.27
High:4.40
Open:4.38
Low:4.38
Close:4.23
52wk High:5.36
52wk Low:3.53
Shares:37.40M
Float Shares:19.92M
Volume Ratio:0.35
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9371
EPS(LYR):-2.0808
ROE:-59.01%
ROA:-28.82%
PB:1.93
PE(LYR):-2.11

Loading ...

Molecular Partners AG Expected to Post a Loss of 35 Rappen a Share - Earnings Preview

Reuters
·
Aug 21

Molecular Partners doses first patients in MP0317 combination study

TIPRANKS
·
Jul 16

Molecular Partners Doses First Patients in Phase 2 Study of Biliary Tract Cancer Therapy

MT Newswires Live
·
Jul 16

Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma

GlobeNewswire
·
Jul 16

Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference

GlobeNewswire
·
Jul 15

LifeSci Capital Sticks to Their Buy Rating for Molecular Partners (MOLN)

TIPRANKS
·
Jul 11

Molecular Partners Makes Progress on Radiotherapy Cancer Candidates

MT Newswires Live
·
Jul 06

Molecular Partners Updates on Clinical Progress Across Expanding Pipeline of DARPin Radiotherapeutics

GlobeNewswire
·
Jul 06

Molecular Partners, Orano Med doses first patient in MP0712 study

TIPRANKS
·
Jul 02

Molecular Partners Doses First Patients in Lung Cancer Trial

MT Newswires Live
·
Jul 02

Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712

GlobeNewswire
·
Jul 02

Analysts Offer Insights on Healthcare Companies: Disc Medicine (IRON), Molecular Partners (MOLN) and Park Dental Partners, Inc. (PARK)

TIPRANKS
·
Jun 05

Molecular Partners to hold trial-in-progress presentations on Phase 1/2a study

TIPRANKS
·
Jun 01

Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1

GlobeNewswire
·
May 30

Molecular Partners to Present at TD Cowen’s 7th Annual Oncology Innovation Summit

GlobeNewswire
·
May 27

Analysts Are Bullish on Top Healthcare Stocks: Molecular Partners (MOLN), Enliven Therapeutics (ELVN)

TIPRANKS
·
May 16

Molecular Partners AG reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Molecular Partners Q1 EPS $(0.45) Misses $(0.38) Estimate

Benzinga Earnings
·
May 13

Press Release: Molecular Partners Reports Financial Results and Highlights for Q1 2026, with Clinical Studies Initiated on MP0712 and MP0317

Dow Jones
·
May 13

Molecular Partners to hold oral presentations on DLL3-targeting Radio-DARPin candidate MP0712 at multiple upcoming scientific conferences

GlobeNewswire
·
May 04